Doctor Victoria Neiman

Dr. Victoria Neiman is an oncologist specializing in internal medicine and clinical oncology. She heads the inpatient oncology department at the Davidoff Cancer Center, a cancer treatment and research center at Beilinson Hospital, Rabin Medical Center, in Petah Tikva. Her clinical practice includes the diagnosis and treatment of various cancers, with a particular focus on genitourinary malignancies.

One of her main areas of expertise is the treatment of kidney, prostate, and bladder cancer. She is involved in the development and evaluation of modern systemic anticancer treatments, including immunotherapy and targeted therapy. Clinical research findings and the selection of treatment based on the characteristics of each patient’s disease play an important role in her practice.

In addition to her clinical work, Dr. Neiman is involved in research and medical education. She has participated in international clinical trials whose findings have been published in leading medical journals, and she teaches oncology. She also practices oncology at Maccabi Healthcare Services and leads a project aimed at expanding access to outpatient immunotherapy.

Key areas:

• Urologic oncology
• Systemic treatment of genitourinary malignancies

The main professional interests of Dr. Victoria Neiman include:

• urologic oncology: kidney, bladder, testicular, and prostate cancers, including innovative immunotherapy for stage IV bladder cancer; assessment of the need for immediate treatment and prostate cancer aggressiveness using the Oncotype DX Genomic Prostate Score test; systemic treatment of metastatic kidney cancer and assessment of the need to combine it with image-guided radiation therapy (IGRT)
• breast cancer treatment: breast cancer staging and treatment planning, assessment of eligibility for breast-conserving surgery, and evaluation of intraoperative radiotherapy (IORT) to minimize radiation exposure and its associated side effects
• immunotherapy
• targeted therapy
• systemic cancer treatment
• personalized cancer treatment
• clinical trials of anticancer drugs
• international phase II and phase III clinical trials
• evaluation of treatment efficacy and safety
• modern treatment approaches for advanced cancer
• oncology research